Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

RDW can be a useful marker for inflammation in alopecia areata patients.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

PRP injections improve periorbital wrinkles and show promise as a treatment.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Retinol may affect immune responses in people with frequent skin boils.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Consider Castleman's disease in similar cases; histology and steroids help diagnose and manage it.

Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.